![]() |
市场调查报告书
商品编码
1297772
全球诊断设备市场 - 2023-2030年Global Diagnostic Device Market - 2023-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
全球诊断设备市场在2022年达到470亿美元,预计到2030年将见证有利可图的增长,达到799亿美元。在2023-2030年的预测期间,市场预计将呈现6.9%的复合增长率。
诊断设备通过实现早期检测、准确诊断、监测疾病、个性化治疗、公共卫生监测和研究,在医疗保健中发挥着关键作用。诊断设备提供客观和精确的信息,协助医疗专业人士做出准确的诊断。诊断设备能够对疾病和状况进行长期监测,帮助医疗服务提供者评估治疗效果并做出必要的调整。
慢性病是长期的健康问题,需要持续管理和医疗护理。它们是世界范围内的主要健康问题,对个人、医疗系统和社会有着深远的影响。慢性病是全世界死亡和残疾的最大原因。
据世界卫生组织(WHO)称,非传染性疾病(NCDs),包括心血管疾病、癌症、慢性呼吸道疾病和糖尿病等慢性疾病,占全球所有死亡的近75%。另一方面,糖尿病是一种以血糖水平升高为特征的慢性代谢性疾病。
根据国际糖尿病联合会的数据,2019年大约有4.63亿成年人(20-79岁)患有糖尿病,如果目前的趋势继续下去,这个数字预计到2045年将攀升至7亿。而这些因素促成了市场的扩张。
诊断设备的成本会因各种因素而有很大差异,包括设备的类型、其复杂性、功能、品牌和购买的地区。例如,超声机使用声波来产生身体内部结构的图像。超声波机的成本可以有很大的不同,这取决于其预期用途和功能。便携式或手持式超声设备可能从3000美元到15000美元不等,而医疗机构使用的高端、基于推车的系统可能需要数万或更多。因而程序的成本将阻碍市场的增长。
COVID-19的大流行对诊断设备及其使用产生了广泛影响。例如,这场大流行促使人们对COVID-19诊断测试产生了迄今为止闻所未闻的需求。COVID-19的感染已经用诊断工具,如PCR设备和快速抗原测定法进行检测和诊断。检测需求的增加使这些设备的制造和使用在世界范围内得到了提高。
COVID-19大流行对诊断设备的格局产生了重大影响,导致需求增加、技术进步、供应链问题、重点转移和监管程序的修改。这些变化对大流行病管理有短期影响,对诊断技术和医疗服务有长期影响。
俄罗斯-乌克兰战争估计对全球诊断设备市场的影响很小,因为该地区的流行率低,而且没有关键的市场参与者。然而,在预测期内,原材料、测试产品和设备的进出口的影响预计对全球诊断设备市场的影响不大。
人工智能预计将对全球子痫前期市场产生积极的影响。人工智能诊断小工具可以在治疗效果通常较好的时候更早诊断出疾病。这些设备可以持续监测和分析病人数据,允许实时检测健康指数的异常或变化。早期发现可以迅速采取行动,这可能会减少疾病的发展并改善预后。
The Global Diagnostic Device Market reached US$ 47 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 79.9 billion by 2030. The market is expected to exhibit a CAGR of 6.9% during the forecast period 2023-2030.
Diagnostic devices play a pivotal role in healthcare by enabling early detection, accurate diagnosis, monitoring of diseases, personalized treatment, public health surveillance, and research. Diagnostic devices provide objective and precise information, assisting healthcare professionals in making accurate diagnoses. Diagnostic devices enable the monitoring of diseases and conditions over time, helping healthcare providers assess the effectiveness of treatments and make necessary adjustments.
Chronic diseases are long-term health issues that necessitate continuing management and medical care. They are a major worldwide health concern with far-reaching consequences for individuals, healthcare systems, and society. Chronic diseases are the biggest cause of death and disability around the world.
Noncommunicable diseases (NCDs), which include chronic diseases such as cardiovascular disease, cancer, chronic respiratory diseases, and diabetes, account for nearly 75% of all deaths worldwide, according to the World Health Organisation (WHO). Diabetes, on the other hand, is a chronic metabolic condition characterised by elevated blood sugar levels.
According to the International Diabetes Federation, roughly 463 million adults (20-79 years) had diabetes in 2019, and this figure is expected to climb to 700 million by 2045 if current trends continue. And these factors contribute to market expansion.
The cost of diagnostic devices can vary significantly depending on various factors, including the type of device, its complexity, features, brand, and the region in which it is being purchased. For instance, Ultrasound machines use sound waves to produce images of the body's internal structures. The cost of ultrasound machines can vary significantly depending on their intended use and features. Portable or handheld ultrasound devices may range from $3,000 to $15,000, while high-end, cart-based systems used in medical facilities can cost tens of thousands or more. And thus the cost of procedures will hamper the market growth.
The pandemic of COVID-19 has had an extensive effect on diagnostic devices and their use. For example, the pandemic prompted a hitherto unheard-of demand for COVID-19 diagnostic testing. COVID-19 infections have been detected and diagnosed using diagnostic tools such as PCR equipment and rapid antigen assays. The increased demand for testing has increased the manufacturing and use of these devices worldwide.
The COVID-19 pandemic has substantially impacted the diagnostic device landscape, resulting in increased demand, technological advances, supply chain issues, shifts in focus, and regulatory procedure modifications. These changes have short-term ramifications for pandemic management and long-term implications for diagnostic technologies and healthcare delivery.
The Russia-Ukraine is estimated to have a minimal impact on the global diagnostic device market owing to the low prevalence and absence of key market players in this region. However, the effect of the import and export of raw materials, test products, and devices is anticipated to have little influence over the global diagnostic device market in the forecast period.
Artificial intelligence is anticipated to impact the global preeclampsia market positively. AI-enabled diagnostic gadgets can diagnose diseases earlier when treatment outcomes are usually better. These devices can continually monitor and analyze patient data, allowing for real-time detection of irregularities or changes in health indices. Early discovery allows quick action, which may reduce illness development and improve prognosis.
The ultrasound systems segment is estimated to hold most of the diagnostic device market share during the forecast period.
The ultrasound systems ' product type holds about 38.6% of the total diagnostic device market in the forecast period. Ultrasound systems are versatile diagnostic equipment that generates real-time images of the body's internal components using high-frequency sound waves.
They are commonly employed in a variety of medical professions and clinical situations. In radiology, ultrasound is commonly used to evaluate various organs and tissues. It's perfect for imaging soft tissues, including the liver, kidneys, gallbladder, spleen, and thyroid.
And manufacturers are launching new products and highly investing by collaborating with other players to expand their portfolio globally.For instance, on August 26, 2021, Probo Medical, a global leader in medical imaging equipment, parts, repair, and service, has agreed to become an authorised distributor of Mindray North America's ultrasound solutions.
Probo will provide clinicians with immediate and direct access to a wide range of Mindray's unique, category-leading ultrasound imaging instruments and accompanying accessories as a result of this collaboration. And as a result, the market is driven by the leading players' product launches.
Europe holds the second-largest Global Diagnostic Device Market share, accounting for approximately 28.9% in the forecast period. The greying of Europe is a demographic phenomenon typified by a decline in fertility, a decrease in mortality rate, and a higher life expectancy among European populations. Furthermore, Europe's population is quickly aging, with a growing number of older people.
People's chance of developing chronic diseases such as cardiovascular disease, cancer, diabetes, and respiratory ailments rises as they age. The aging population places a substantial strain on healthcare systems in terms of managing and treating chronic illnesses. For instance, according to World Economic Forum 2022, the European Union and other countries will likely face rapidly aging populations. By 2100, more than 30% of the EU population will be 65 or older. This demographic shift can potentially alter the region's economic prospects significantly.
The major global players in the market include: GE Healthcare, Siemens Healthineers, Koninklijke Philips N.V, Canon Medical Systems Corporation, Carestream Health, Inc, Hologic, Inc, Allengers Medical Systems, SternMed, Neusoft Medical Systems, Medtronic Plc, among others.
The Global Diagnostic Device Market Report Would Provide Approximately 53 Tables, 54 Figures And 195 pages.
LIST NOT EXHAUSTIVE